Cardiovascular Associates of America

The platform was formed in partnership with Webster Equity Partners, a Boston-area private equity firm that specializes in healthcare services investments. Webster has a history of building single-specialty physician practice management companies and closed its latest flagship fund at $875 million in 2023. The firm typically retains majority ownership in its platform investments while preserving physician equity stakes.

The firm targets independent cardiology groups with strong local market positions and aging partner bases. Sourcing relies on a combination of inbound interest from physicians approaching retirement, relationships with healthcare investment bankers and brokers, and direct outreach by Webster's deal origination team. The fragmented nature of cardiology — with thousands of small practices nationally — provides a large addressable pipeline.

It is neither. CVA USA is a portfolio company of Webster Equity Partners, a private equity fund manager. The platform functions as an operating company that acquires, integrates, and manages cardiology practices on behalf of institutional limited partners who invest in Webster's funds. It does not operate as a family office or a direct family-backed investment vehicle.

CVA USA is an operating asset, not an institutional investor. The entity itself makes direct acquisitions of physician practices using equity capital supplied by Webster Equity Partners' private equity funds. It does not make fund commitments to outside managers. The capital at work is deployment into wholly or majority-owned operating subsidiaries under the CVA USA holding company.

The platform is exclusively focused on cardiovascular medicine, including general cardiology, interventional cardiology, and electrophysiology. Ancillary services typically include cardiac imaging, vascular ultrasound, and ambulatory cardiac monitoring. Some affiliated practices also operate office-based catheterization labs or ambulatory surgery centers, though vascular surgery and cardiothoracic surgery are generally excluded from the roll-up thesis.